DGAP-News: UMS United Medical Systems International AG: UMS AG reports on the 2014 financial statements Earnings per share of EUR 7.72 Management Board and Supervisory Board to propose a dividend of EUR 7.53 per share


 
DGAP-News: UMS United Medical Systems International AG / Key word(s): Final Results/Dividend UMS United Medical Systems International AG: UMS AG reports on the 2014 financial statements Earnings per share of EUR 7.72 Management Board and Supervisory Board to propose a dividend of EUR 7.53 per share 16.03.2015 / 14:00 --------------------------------------------------------------------- UMS AG reports on the 2014 financial statements Earnings per share of EUR 7.72 Management Board and Supervisory Board to propose a dividend of EUR 7.53 per share Hamburg, March 16, 2015. UMS United Medical Systems International AG (UMS/ ISIN DE0005493654) today reported on its financial statements for 2014. These financials were affected by the sale of its interest in United Medical Systems (DE), Inc. and thus practically all of its assets to UMS Acquisition Holdings, Inc. The purchase price was received in UMS AG's account in November 2014. As a result of this sale, earnings per share rose to EUR 7.72. UMS AG's equity amounted to EUR 53.8 million at the end of 2014, up from EUR 19.7 million at the end of 2013. On the basis of 4,757,668 UMS shares at the end of 2014, the equity per UMS share at the end of 2014 stood at EUR 11.31. Through the sale mentioned above, UMS AG's cash and cash equivalents increased from EUR 0.06 million at the end of 2013 to EUR 54.0 million at the end of 2014. This accounted for almost all of the company's assets of EUR 54.4 million at the end of 2014. The Management Board and the Supervisory Board of the Company will propose a dividend of EUR 7.53 per UMS share at the annual shareholders' meeting to be held on April 27, 2015 in Hamburg. UMS AG's financial statements for 2014 are available on the company's website at www.umsag.com. About UMS International AG UMS United Medical Systems International AG is a corporation listed in the Prime Standard segment of Deutsche Börse AG. The Company sold its interest in United Medical Systems (DE), Inc. and thus essentially all its assets on August 14, 2014. The shareholders agreed to this sale at the special meeting held on September 25, 2014. The agreement was consummated on November 11, 2014. Now that the assets have been sold, the purpose of the Company is to manage its own assets. Contact Christian Möller, Tel: (040) 50 01 77-00, Fax: (040) 50 01 77-77, E-Mail: [email protected] --------------------------------------------------------------------- 16.03.2015 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: UMS United Medical Systems International AG Borsteler Chaussee 53 22453 Hamburg Germany Phone: +49 (0)40 - 500 177 - 00 Fax: +49 (0)40 - 500 177 - 77 E-mail: [email protected] Internet: www.umsag.com ISIN: DE0005493654 WKN: 549365 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 332501 16.03.2015


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022e
Umsatzerlöse1 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBITDA1,2 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBITDA-Marge3 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBIT1,4 0,00 0,00 0,00 0,00 0,00 0,00 0,00
EBIT-Marge5 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Jahresüberschuss1 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Netto-Marge6 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Cashflow1,7 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Ergebnis je Aktie8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Dividende8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer:

INVESTOR-INFORMATIONEN
©boersengefluester.de
WKN Kurs in € Einschätzung Börsenwert in Mio. €
0,000 0,00
KGV 2023e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
0,00 0,00 0,00 0,00
KBV KCV KUV EV/EBITDA
0,00 0,00 0,00 0,00
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
0,00% 0,00% 0,00% 0,00%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu UMS United Medical Systems International AG  ISIN: DE0005493654 können Sie bei EQS abrufen


in Auflösung , 549365